Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis

Viral Immunology

Volumn 24, Issue 2, 2011, Pages 131-142

  Smith, Jennifer Humberd ^a   Nagy, Tamas ^a   Barber, Jamie ^a   Brooks, Paula ^a   Tompkins, S Mark ^a   Tripp, Ralph A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; DISEASE EXACERBATION; FEMALE; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; INOCULATION; KOBUVIRUS; LUNG ALVEOLUS CELL; LUNG DISEASE; LUNG INFECTION; LUNG INFILTRATE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; VIRUS PATHOGENESIS;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; AEROSOLS; ANIMALS; FEMALE; INFLUENZA A VIRUS, H3N2 SUBTYPE; LUNG; LUNG DISEASES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS;

MUS; ORTHOMYXOVIRIDAE;

EID: 79953246996     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0085     Document Type: Article

References (55)

1. Alford RH, Kasel JA, Gerone PJ, and Knight V: Human in-fluenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966;122:800-804.
2. Allan W, Carding SR, Eichelberger M, and Doherty PC: hsp65 mRNA+ macrophages and gamma delta T cells in influenza virus-infected mice depleted of the CD4+ and CD8+ lymphocyte subsets. Microb Pathog 1993;14:75-84
3. Allan W, Tabi Z, Cleary A, and Doherty PC: Cellular events in the lymph node and lung of mice with influenza. Con-sequences of depleting CD4+ T cells. J Immunol 1990;144: 3980-3986. (Pubitemid 20171213)
4. Barnard DL: Animal models for the study of influenza pathogenesis and therapy. Antiviral Res 2009;82:A110-A122.
5. Baumgarth N, and Kelso A: In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol 1996;70:4411-4418. (Pubitemid 26187442)
6. Belser JA, Wadford DA, Pappas C, et al.: Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol 1996;84:4194-4203.
7. Brydon EW, Morris SJ, and Sweet C: Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol Rev 2005;29:837-850. (Pubitemid 41139183)
8. Buchweitz JP, Harkema JR, and Kaminski NE: Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol Pathol 2007;35:424-435.
9. Carding SR, Allan W, Kyes S, Hayday A, Bottomly K, and Doherty PC: Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells. J Exp Med 1990;172:1225-1231. (Pubitemid 20343224)
10. Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, and Kluger MJ: Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 1995;268:R78-R84.
11. Deng G, Bi J, Kong F, et al.: Acute respiratory distress syn-drome induced by H9N2 virus in mice. Arch Virol 1995;155: 187-195.
12. Dilbeck PM, and McElwain TF: Immunohistochemical detection of Coxiella burnetti in formalin-fixed placenta. J Vet Diagn Invest 1994;6:125-127.
13. Frankova V: Inhalatory infection of mice with influenza A0/PR8 virus. I. The site of primary virus replication and its spread in the respiratory tract. Acta Virol 1975;19:29-34.
14. Gentile D, Doyle W, Whiteside T, Fireman P, Hayden FG, and Skoner D: Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection Clin Diagn Lab Immunol 1998;5:604-608. (Pubitemid 29030752)
15. Gerhard W, Mozdzanowska K, Furchner M, Washko G, and Maiese K: Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol Rev 1997;159:95-103. (Pubitemid 27499862)
16. Govorkova EA, Kaverin NV, Gubareva LV, Meignier B, and Webster RG: Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J Infect Dis 1995;172:250-253.
17. Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, and Braciale TJ: Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med 1993;178:1725-1732. (Pubitemid 23318451)
18. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, and Straus SE: Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101:643-649. (Pubitemid 28084248)
19. He F, Du Q, Ho Y, and Kwang J: Immunohistochemical detection of influenza virus infection in formalin-fixed tis-sues with anti-H5 monoclonal antibody recognizing FFWTILKP. J Virol Methods 2009;155:25-33.
20. Hennet T, Ziltener HJ, Frei K, and Peterhans E: A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 1992;149:932-939.
21. Imai Y, Kuba K, Neely GG, et al.: Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008;133:235-249. (Pubitemid 351512299)
22. Jefferson T, Foxlee R, Del Mar C, et al.: Interventions for the interruption or reduction of the spread of respiratory viru-ses. Cochrane Database Syst Rev 2007;CD006207.
23. Jemski JV, and Walker JS: Aerosol vaccination of mice with a live, temperature-sensitive recombinant influenza virus. Infect Immun 1976;13:818-824.
24. Johansson BE, and Kilbourne ED: Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection. J Virol Methods 1991;35: 109-114.
25. Knight V: Viruses as agents of airborne contagion. Ann NY Acad Sci 1980;353:147-156. (Pubitemid 11185056)
26. Knight V: Aerosol treatment of influenza. Cardiovasc Res Cent Bull 1981;19:118-128. (Pubitemid 12083771)
27. Kobasa D, Jones SM, Shinya K, et al.: Aberrant innate im-mune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007;445:319-323. (Pubitemid 46122819)
28. Kobasa D, Takada A, Shinya K, et al.: Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004;431:703-707. (Pubitemid 39382618)
29. Lipatov AS, Andreansky S, Webby RJ, et al.: Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B-and T-cell responses. J Gen Virol 2005;86:1121-1130. (Pubitemid 40485670)
30. Little JW, Douglas RG Jr, Hall WJ, and Roth FK: Attenuated influenza produced by experimental intranasal inoculation J Med Virol 1979;3:177-188. (Pubitemid 9155020)
31. Maines TR, Szretter KJ, Perrone L, et al.: Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 2008;225:68-84.
32. Maltezou HC: Nosocomial influenza: new concepts and practice. Curr Opin Infect Dis 2008;21:337-343.
33. McLoughlin RM, Witowski J, Robson RL, et al.: Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 2003;112:598-607. (Pubitemid 38056344)
34. Mount AM, and Belz GT: Mouse models of viral infection influenza infection in the lung. Methods Mol Biol 2003;595: 299-318.
35. Mozdzanowska K, Maiese K, and Gerhard W: Th cell-deficient mice control influenza virus infection more effec-tively than Th-and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J Immunol 2000;164:2635-2643. (Pubitemid 30115495)
36. Nguyen HH, van Ginkel FW, Vu HL, Novak MJ, McGhee JR, and Mestecky J: Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or hetero-subtypic immunity to influenza A virus infection in mice. J Virol 2000;74:5495-5501. (Pubitemid 30346581)
37. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, and Maeda H: Oxygen radicals in influenza-induced pathogen-esis and treatment with pyran polymer-conjugated SOD. Science 1989;244:974-976. (Pubitemid 19152287)
38. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, and Tumpey TM: H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macro-phages and neutrophils in the lungs of mice. PLoS Pathog 2008;4:e1000115.
39. Price GE, Gaszewska-Mastarlarz A, and Moskophidis D: The role of alpha/beta and gamma interferons in develop-ment of immunity to influenza A virus in mice. J Virol 2000;74:3996-4003. (Pubitemid 30214404)
40. Reed LJ, and Meunch H: A simple method for estimating fifty percent endpoints. Am J Hygiene 1938;27:493-497.
41. Salgado CD, Farr BM, Hall KK, and Hayden FG: Influenza in the acute hospital setting. Lancet Infect Dis 2002;2:145-155. (Pubitemid 34462449)
42. Scott GH, and Sydiskis RJ: Responses of mice immunized with influenza virus by serosol and parenteral routes. Infect Immun 1976;13:696-703.
43. Skoner DP, Gentile DA, Patel A, and Doyle WJ: Evidence for cytokine mediation of disease expression in adults experi-mentally infected with influenza A virus. J Infect Dis 1999;180:10-14 (Pubitemid 29293911)
44. Snyder MH, Stephenson EH,. Young H, et al.: Infectivity and antigenicity of live avian-human influenza A reassortant virus: comparison of intranasal and aerosol routes in squirrel monkeys. J Infect Dis 1986;154:709-711.
45. Svitek N, Rudd PA, Obojes K, Pillet S, and von Messling V: Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 2008;376: 53-59.
46. Szretter KJ, Gangappa S, Lu X, et al.: Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007;81:2736-2744. (Pubitemid 46447038)
47. Tate MD, Brooks AG, and Reading PC: The role of neutro-phils in the upper and lower respiratory tract during influ-enza virus infection of mice. Respir Res 2008;9:57.
48. Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, and Reading PC: Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 2009;183:7441-7450.
49. Tellier R Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006;12:1657-1662. (Pubitemid 44674240)
50. Thompson WW, Shay DK,. WeintraubE, Brammer L, Bridges CB, Cox NJ, and Fukuda K: Influenza-associated hospitali-zations in the United States. JAMA 2004;292:1333-1340.
51. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, and Fukuda K: Mortality associated with in-fluenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186. (Pubitemid 36068705)
52. Tripp RA, and Tompkins SM: Animal models for evaluation of influenza vaccines. Curr Top Microbiol Immunol 2009;333:397-412.
53. Turner SJ, Kedzierska K, La Gruta NL, Webby R, and Doherty PC: Characterization of CD8+ T cell repertoire di-versity and persistence in the influenza A virus model of localized, transient infection. Semin Immunol 2004;16: 179-184. (Pubitemid 38569898)
54. Van Der Laan JW, Herberts C, Lambkin-Williams R, Boyers A, Mann AJ, and Oxford J: Animal models in influenza vaccine testing. Expert Rev Vaccines 2008;7:783-793.
55. Webster RG, Laver WG, and Kilbourne ED: Reactions of antibodies with surface antigens of influenza virus. J Gen Virol 1968;3:315-326.